/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Antiplatelet therapy and risk of adverse cardiovascular events in peripheral artery disease
Event: ESC Congress 2022
Topic: Secondary Prevention
Session: Secondary prevention 1
Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: Nationwide trends between 1997 and 2016
Event: ESC Congress 2021 - The Digital Experience
Topic: Peripheral Artery Disease
Session: Young Investigator Awards Session in Population Sciences
Time trends in use of cardioprotective medication in patients with peripheral artery disease between 1997 and 2016: a nationwide study
Event: ESC Congress 2020
Topic: Pharmacotherapy
Session: Peripheral Vascular and Cerebrovascular Disease ePosters
Temporal trends in risk of atrial fibrillation and stroke in patients with peripheral artery disease between 1997 to 2015
Event: ESC Congress 2019
Topic: Epidemiology, Prognosis, Outcome
Session: Comorbidities and prognosis in peripheral artery disease
Closure of left atrial appendage in patients with atrial fibrillation undergoing first-time coronary bypass graft surgery is associated with lower risk of stroke
Event: ESC Congress 2018
Topic: Stroke Prevention
Session: Atrial fibrillation - Stroke prevention
ESC 365 is supported by
